How digital health companies are capitalizing on the GLP-1 boom, CNBC, May 25, 2024
Though data is still emerging, it appears that GLP-1 RAs show promise as a potential adjunct medication for IIH patients with benefits that extend beyond weight loss
Taking your semaglutide as prescribed, watching the scale drop steadily, feeling more in control of your eating habits than you have in years
Their advantages stem from the nanoscale droplet size, offering high solubilization capacity, thermodynamic and kinetic stabilitysurpassing that of conventional dosage forms
Other signs include feeling less hungry between meals, improved mood and mental clarity, and better workout performance
When combined with alcohol's inhibition of glucose production, the risk of hypoglycemia may increase, especially in patients also taking insulin or sulfonylureas